IVM: (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17 -oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside

IVM is a Ligand Of Interest in 5VDH designated by the RCSB


Best-fitted instance in this entry
Other instances in this entry
Best-fitted instance in this entry
Best-fitted PDB instances with same target (top 5)
Best-fitted instance in this entry
Best-fitted PDB instances with different target (top 5)
IdentifierRanking for goodness of fit Ranking for geometry Real space R factor Real space correlation coefficient RMSZ-bond-length RMSZ-bond-angleOutliers of bond length Outliers of bond angle Atomic clashesStereochemical errorsModel completenessAverage occupancy
5VDH_IVM_A_403 35% 24% 0.223 0.9131.86 1.28 8 930100%1
5VDH_IVM_D_403 34% 23% 0.209 0.8921.84 1.35 8 1120100%1
5VDH_IVM_B_403 27% 23% 0.243 0.8941.83 1.36 8 1020100%1
5VDH_IVM_E_403 26% 24% 0.214 0.8571.81 1.34 8 1100100%1
5VDH_IVM_C_403 25% 22% 0.239 0.8771.83 1.39 8 1320100%1
5VDI_IVM_C_403 42% 16% 0.205 0.9251.93 1.73 11 19 00100%1
4WVD_IVM_A_505 50% 4% 0.186 0.9383.38 2.16 27 32 60100%1
3RI5_IVM_B_349 33% 38% 0.231 0.9130.79 1.62 1 1710100%1
3RIF_IVM_D_402 31% 37% 0.232 0.9030.8 1.64 1 1620100%1
3RIA_IVM_A_348 23% 37% 0.281 0.9060.8 1.63 1 1510100%1